Sleep Timing and Insulin Resistance in Adolescents With Obesity
Investigating the Relationship Between Circadian Phase and Insulin Resistance in Obese Adolescents
2 other identifiers
observational
25
1 country
1
Brief Summary
This study examines the relationship between sleep timing and insulin resistance in adolescents with obesity. The investigators also aim to develop a physiologically-based mathematical model of adolescent sleep/wake and circadian interactions.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Oct 2015
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2015
CompletedFirst Submitted
Initial submission to the registry
October 22, 2015
CompletedFirst Posted
Study publicly available on registry
October 23, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2017
CompletedResults Posted
Study results publicly available
February 19, 2020
CompletedFebruary 19, 2020
February 1, 2020
1.6 years
October 22, 2015
January 23, 2020
February 6, 2020
Conditions
Outcome Measures
Primary Outcomes (2)
Dim Light Melatonin Onset and Offset
\~1mL saliva was collected at 30- to 60- minute intervals in dim light (\<5 lux in the angle of gaze, approximately the light level of candlelight or civil twilight) from approximately 5pm until noon the next day. Dim light melatonin onset (DLMOn) was defined as the linear interpolated clock time at which evening salivary melatonin concentrations increased and remained above a threshold of 3pg/mL. Melatonin offset (DLMOff) was the linear interpolated clock time at which salivary melatonin concentrations fell below this threshold. Later DLMOn and DLMOff are indicative of a later circadian rhythm.
1 day
Insulin Sensitivity
After an overnight fast, participants completed an oral glucose tolerance test (OGTT) in the morning. Participants consumed a 75g dextrose drink and serum for glucose and insulin concentrations were collected at baseline and every 30 minutes for 3 hours. The homeostatic model assessment for insulin resistance (HOMA-IR) was calculated as \[fasting insulin (μU/ml) x fasting glucose (mmol/l)\] / 22.5); lower HOMA-IR indicates better insulin sensitivity. The Matsuda Index was calculated as √10,000 / \[\[fasting insulin (μU/ml) x fasting glucose (mmol/l)\] x \[mean OSTT insulin (μU/ml) x mean OSTT glucose (mmol/l)\]\]; high Matsuda Index indicates better insulin sensitivity.
3 hours
Eligibility Criteria
Adolescents with obesity
You may qualify if:
- High school students between the ages of 15-19
- BMI \> 90th percentile
- Tanner stage 2 or greater
You may not qualify if:
- Any medications that affect insulin resistance or sleep (e.g., metformin, hormonal contraception, stimulants, atypical antipsychotics)
- Regular use of melatonin or sleep aids
- A prior diagnosis of obstructive sleep apnea, diabetes (HbA1c \> 6.5), liver disease other than non-alcoholic fatty liver disease, pregnancy or breastfeeding
- IQ \< 70 or severe mental illness that may impact sleep (e.g., schizophrenia, psychotic episodes)
- Not enrolled in a traditional high school academic program (e.g., home school students)
- Night shift employment
- Travel across more than 2 time zones in the month prior to the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Colorado Anschutz Medical Campus/Children's Hospital Colorado
Aurora, Colorado, 80045, United States
Related Publications (1)
Simon SL, McWhirter L, Diniz Behn C, Bubar KM, Kaar JL, Pyle L, Rahat H, Garcia-Reyes Y, Carreau AM, Wright KP, Nadeau KJ, Cree-Green M. Morning Circadian Misalignment Is Associated With Insulin Resistance in Girls With Obesity and Polycystic Ovarian Syndrome. J Clin Endocrinol Metab. 2019 Aug 1;104(8):3525-3534. doi: 10.1210/jc.2018-02385.
PMID: 30888398DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Stacey L. Simon
- Organization
- University of Colorado Anschutz Medical Campus
Study Officials
- PRINCIPAL INVESTIGATOR
Stacey L Simon, PhD
University of Colorado Denver & Children's Hospital Colorado
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 22, 2015
First Posted
October 23, 2015
Study Start
October 1, 2015
Primary Completion
May 1, 2017
Study Completion
May 1, 2017
Last Updated
February 19, 2020
Results First Posted
February 19, 2020
Record last verified: 2020-02